EMPOWERING
PROTEIN ENGINEERING
Site-specific modification of proteins through unique genetic code expansion platform
UNIQUE BIOCONJUGATION PLATFORM
BrickBio's platform enables custom tailoring of any protein with homogenous site-specific and site-selective modifications for both research and therapeutic applications. This technology further expands the protein engineering life cycle by developing unique biologics that wouldn’t exist otherwise.
OUR
TECHNOLOGY
PROTEIN ENGINEERING​
Improve protein characteristics, such as increasing serum half-life, improved specificity, or boosted activity.
BIOCONJUGATION KITS
​
RUO kits are available for a variety of applications: dye-linked, oligo-linked,
and immuno-based assays
PHARMA PARTNERSHIPS​
​
Development of custom protein-based therapeutics or research assays to drastically improve R&D productivity.
ANTIBODY CONJUGATION
Empowering the next generation of ADCs with improved efficacy, dosage, and modification homogeneity
IN VIVO CELL BASED ASSAYS
Investigation of protein half-life or
protein-protein interactions in vivo with
high temporal control
THERAPEUTIC PIPELINE
We are currently developing early-stage biologic therapeutic candidates with improved characteristics​
OUR TEAM
CEO, Co-Founder,
TIGER GENE
VP, COMMERCIAL
DEVELOPMENT
SENIOR ADVISOR &
CHAIRMAN OF SAB
HEAD OF BUSINESS DEVELOPMENT
CONTACT
BRICKBIO
OUR ADDRESS
10 New Street,
Boston, MA, 02128, USA
For any general inquiries, please fill in the following contact form:
